Clinical Trial Update: Bendamustine and Idarubicin in Treating Older Patients With Previously Untreated AML or MDS [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes the Phase 1/2 results for the combination of bendamustine and idarubicin in older patients with previously untreated acute …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Bendamustine (Bendamustine)
• Idarubicin (idarubicin)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-08-18